A Uro-Oncology Fellowship (also known as a Urologic Oncology Fellowship) is a specialized training program designed for urologists who wish to advance their expertise in diagnosing, treating, and managing cancers of the urinary tract and male reproductive organs. These cancers include prostate, bladder, kidney, testicular, and penile cancers. The fellowship typically lasts one to three years and combines both clinical and research training to develop comprehensive skills in oncologic urology.
During the fellowship, physicians gain experience in performing complex cancer surgeries, including minimally invasive techniques such as laparoscopic and robotic-assisted surgeries, as well as open surgical procedures. Fellows are trained in advanced diagnostic tools like MRI fusion-guided biopsies, molecular imaging, and next-generation sequencing, which are essential for accurate diagnosis and personalized treatment planning. They also learn about the latest systemic therapies, including immunotherapy and targeted therapies, as well as the management of chemotherapy and radiation therapy in collaboration with other oncology specialists.
The fellowship program emphasizes research, encouraging fellows to engage in clinical trials, translational research, and epidemiological studies to contribute to advancements in urologic oncology. This dual focus on clinical practice and research prepares fellows to become leaders in academic and clinical settings, promoting evidence-based care and improving outcomes for patients with urologic cancers.
